DJIA 18,214.42 0.00 0.00%
NASDAQ 4,987.89 0.00 0.00%
S&P 500 2,110.74 0.00 0.00%
market minute promo

Verastem, Inc. (NASDAQ: VSTM)

7.69 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VSTM $7.69 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.96
Previous Close $7.69
Daily Range $7.66 - $8.00
52-Week Range $6.78 - $14.92
Market Cap $199.1M
P/E Ratio -4.00
Dividend (Yield) $0.00 (0.0%)
Volume 375,863
Average Daily Volume 700,623
Current FY EPS -$2.09

Sector

Healthcare

Industry

Drug Makers

Verastem, Inc. (VSTM) Description

Verastem Inc is a biopharmaceutical company focused on discovering and developing proprietary small molecule drugs targeting cancer stem cells along with proprietary companion diagnostics. Website: http://www.verastem.com/

News & Commentary Rss Feed

Did Researchers Just Discover the Cause of Pancreatic Cancer?

Pancreatic cancer is the fourth-leading cause of cancer-related death, but researchers may have moved one step closer to discovering a cure this past week.

Novartis, Verastem & Cepheid Making Biotech Headlines On Friday

3 Biotech Stocks You Won't Want To Miss In 2015

Thursday 1/29 Insider Buying Report: VSTM, OKSB

The Absurdity of Flex Pharma IPO: 2 Spices and a Veg Net $86M

Recent Offering Provides Great Opportunity To Buy Verastem Before Significant 2015 Catalysts

3 Biotech IPOs Debuting This Week

5 Biotech Secondaries Traders Are Watching

US Stock Futures Surge Ahead Of Earnings

Verastem Doses First Patient in Phase 1 Clinical Trial Evaluating VS-5584 in Combination with VS-606

Verastem Doses First Patient in Phase 1 Clinical Trial Evaluating VS-5584 in Combination with VS-6063 in Mesothelioma

See More VSTM News...